Trigeminal neuralgia (1:30), early medication abortion (4:30), sodium-glucose cotransporter-2 inhibitors (6:00), female sexual dysfunction (8:40), per- and polyfluoroalkyl substances (12:30), and methotrexate for juvenile idiopathic arthritis (17:20).

Buprenorphine for opioid use disorder (1:30), triptans for acute migraine (5:30), premenstrual syndrome (6:50), pain management for IUD insertion (11:00), liver fibrosis stage in chronic hepatitis C infection (12:30), and cold water immersion for muscle soreness (14:30).

Labor management (1:30), acute migraine headache (4:00), tirzepatide for sleep apnea (8:20), options for unintended pregnancy (11:20), artificial intelligence scribes (15:00), and testosterone replacement in men with sexual dysfunction (16:50).

Down syndrome (1:30), zuranolone for postpartum depression (7:50), muscle relaxants for chronic pain (10:20), temporal artery ultrasound (12:00), pretravel consultation (15:40), and high-flow nasal cannula for bronchiolitis (19:20).

Nicotine electronic cigarettes (1:30), acute bronchitis (4:10), berdazimer (6:40), cardiac rehabilitation (11:40), chronic pelvic pain (13:50), and mineralocorticoid receptor antagonists in heart failure (22:10).

Fatigue in kidney failure (1:30), gastric cancer (3:50), carpal tunnel injections (6:50), sudden infant death syndrome (9:30), plantar fasciitis (13:20), and measuring ceramide to predict cardiovascular events (15:10).

Cardiovascular risk prediction (1:30), topical steroids for phimosis (3:20), genital warts (7:10), psilocybin for depression (12:00), lower extremity abnormalities in children (13:30), and atrial fibrillation (22:10).

Early childhood concerns (1:30), probiotics to prevent urinary tract infections (7:00), triple therapy for chronic obstructive pulmonary disease (8:50), sudden vision loss (11:20), macular degeneration (15:30), and an AFP Clinical Answers lightening round (19:00).

Jaundice in adults (1:30), gepirone for depression (8:20), steroid injections for degenerative joint disease of the hip (12:20), dysuria (14:50), hip osteoarthritis (19:00), and diabetic kidney disease (21:00).

Mildly elevated liver transaminase levels (1:30), overdiagnosis of myocardial infarction (6:00), predicting bleeding risk in atrial fibrillation (8:30), management of keloids and hypertrophic scars (12:10), weight loss and knee osteoarthritis (15:30), and vitamin D (18:20).